188 research outputs found

    Introduction: “Engaging with the writings of Denise Ferreira da Silva”

    Get PDF
    This is the final version. Available from Berghahn Journals via the DOI in this record. This interdisciplinary forum convenes a wide-ranging conversation centred around the writings of Denise Ferreira da Silva, whose unrelenting inquiry locates the workings of raciality in the very constitution of the modern subject, and, relatedly, global and historical consciousness. Da Silva’s excavation of raciality is consequently expansive in its implications and fundamental in its focus. Throughout her oeuvre, including Unpayable Debt (2022) and Toward a Global Idea of Race (2007), the crucial role of ‘law’ in legitimizing the modern, global racial and economic order remains a central problem. Da Silva’s decolonial agenda will meet with immediate sympathy from many in anthropology – a discipline that has engaged in sustained auto-critique of its own complicity in racialized colonial rule for decades (see Asad 1975; Lewis 1973; Pels and Salemink 2000; for a contemporary instance, cf. Price 2011). However, da Silva shows that any narrow focus on specifc direct linkages to related problematics of knowledge production occludes the constitutive role of modern subjectivity in the globalization of modern juridical rule itself. The ambition of da Silva’s excavation addresses, among other things, such recurring questions for legal anthropology as: ‘who has law and in what sense can diferent populations be said to have law?’; ‘how has the idea of “law” helped to reproduce the very world wrought by the post-Enlightenment?’; and ‘How might we test the limits of law?

    Nursing Diagnosis Risk for falls: prevalence and clinical profile of hospitalized patients

    Get PDF
    Objectives: to identify the prevalence of the Nursing Diagnosis (ND) Risk for falls in the hospitalizations of adult patients in clinical and surgical units, to characterize the clinical profile and to identify the risk factors of the patients with this ND. Method: a cross-sectional study with 174 patients. The data was collected from the computerized nursing care prescriptions system and on-line hospital records, and analyzed statistically. Results: the prevalence of the ND Risk for falls was 4%. The patients’ profile indicated older adults, males (57%), those hospitalized in the clinical units (63.2%), with a median length of hospitalization of 20 (10-24) days, with neurological illnesses (26%), cardio-vascular illnesses (74.1%) and various co-morbidities (3±1.8). The prevalent risk factors were neurological alterations (43.1%), impaired mobility (35.6%) and extremes of age (10.3%). Conclusion: the findings contributed to evidencing the profile of the patients with a risk of falling hospitalized in clinical and surgical wards, which favors the planning of interventions for preventing this adverse event

    Evaluation of 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole as a Novel Anti-Inflammatory Drug Candidate

    Get PDF
    BACKGROUND: 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole (DIC) is a five-membered heterocyclic compound containing a N-O bond. The anti-inflammatory effects of this compound were studied both in vitro and in vivo. PRINCIPAL FINDINGS: DIC effectively decreased TNF-α and IL-6 release from LPS-stimulated macrophages in a dose dependent manner. DIC diminished the levels of COX-2 with subsequent inhibition of PGE(2) production. DIC also compromised HMGB1 translocation from the nucleus to the cytoplasm. Moreover, DIC prevented the nuclear translocation of NF-κB and inhibited the MAPK pathway. In vivo, DIC inhibited migration of neutrophils to the peritoneal cavity of mice. CONCLUSIONS: This study presents the potential utilization of a synthetic compound, as a lead for the development of novel anti-inflammatory drugs

    Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

    Get PDF
    Pharmacological inhibition of VEGF-A has proven to be effective in inhibiting angiogenesis and vascular leak associated with cancers and various eye diseases. However, little information is currently available on the binding kinetics and relative biological activity of various VEGF inhibitors. Therefore, we have evaluated the binding kinetics of two anti-VEGF antibodies, ranibizumab and bevacizumab, and VEGF Trap (also known as aflibercept), a novel type of soluble decoy receptor, with substantially higher affinity than conventional soluble VEGF receptors. VEGF Trap bound to all isoforms of human VEGF-A tested with subpicomolar affinity. Ranibizumab and bevacizumab also bound human VEGF-A, but with markedly lower affinity. The association rate for VEGF Trap binding to VEGF-A was orders of magnitude faster than that measured for bevacizumab and ranibizumab. Similarly, in cell-based bioassays, VEGF Trap inhibited the activation of VEGFR1 and VEGFR2, as well as VEGF-A induced calcium mobilization and migration in human endothelial cells more potently than ranibizumab or bevacizumab. Only VEGF Trap bound human PlGF and VEGF-B, and inhibited VEGFR1 activation and HUVEC migration induced by PlGF. These data differentiate VEGF Trap from ranibizumab and bevacizumab in terms of its markedly higher affinity for VEGF-A, as well as its ability to bind VEGF-B and PlGF
    corecore